Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anti-inflammatory Effects of Empagliflozin and Gemigliptin on LPS-Stimulated Macrophage via the IKK/NF-κB, MKK7/JNK, and JAK2/STAT1 Signalling Pathways
Nami Lee, Yu Jung Heo, Sung‐E Choi, et al.
Journal of Immunology Research (2021) Vol. 2021, pp. 1-11
Open Access | Times Cited: 101

Showing 1-25 of 101 citing articles:

Neuroprotective Effect of SGLT2 Inhibitors
Agnieszka Pawlos, Marlena Broncel, Ewelina Woźniak, et al.
Molecules (2021) Vol. 26, Iss. 23, pp. 7213-7213
Open Access | Times Cited: 173
Sodium-Glucose Cotransporter 2 Inhibitors Mechanisms of Action: A Review
Jorge I. Fonseca‐Correa, Ricardo Correa‐Rotter
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 153
An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors
Teresa Salvatore, Raffaele Galiero, Alfredo Caturano, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3651-3651
Open Access | Times Cited: 149
Empagliflozin attenuates cardiac microvascular ischemia/reperfusion through activating the AMPKα1/ULK1/FUNDC1/mitophagy pathway
Chen Cai, Zhongzhou Guo, Xing Chang, et al.
Redox Biology (2022) Vol. 52, pp. 102288-102288
Open Access | Times Cited: 143
Inflammation and Oxidative Stress in Diabetic Kidney Disease: The Targets for SGLT2 Inhibitors and GLP-1 Receptor Agonists
Agata Winiarska, Monika Knysak, Katarzyna Nabrdalik, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10822-10822
Open Access | Times Cited: 125
Anti-inflammatory role of SGLT2 inhibitors as part of their anti-atherosclerotic activity: Data from basic science and clinical trials
Lucia Scisciola, Vittoria Cataldo, Fatemeh Taktaz, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 80
Nuclear Factor-κB is a Prime Candidate for the Diagnosis and Control of Inflammatory Cardiovascular Disease
Akira Matsumori
European Cardiology Review (2023) Vol. 18
Open Access | Times Cited: 39
Reno- and cardioprotective molecular mechanisms of SGLT2 inhibitors beyond glycemic control: from bedside to bench
Xin Chen, Carl‐Friedrich Hocher, Linghong Shen, et al.
AJP Cell Physiology (2023) Vol. 325, Iss. 3, pp. C661-C681
Closed Access | Times Cited: 32
New anti-diabetic agents for the treatment of non-alcoholic fatty liver disease: a systematic review and network meta-analysis of randomized controlled trials
Tanawan Kongmalai, Varalak Srinonprasert, Thunyarat Anothaisintawee, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 26
Evaluation of empagliflozin efficacy as a promising anti-aging treatment in mice: In-vivo study
Khalid Obaid, Hayder Adnan Fawzi
Pharmacia (2024) Vol. 71, pp. 1-9
Open Access | Times Cited: 11
Research advances in the anti-inflammatory effects of SGLT inhibitors in type 2 diabetes mellitus
Ruining Zhang, Qingxing Xie, Xi Lu, et al.
Diabetology & Metabolic Syndrome (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 10
Anti-inflammatory activity of essential oil from medicinal plants: An insight into molecular mechanism, in-silico studies and signaling pathways
Lopamudra Subudhi, Hrudayanath Thatoi, Amrita Banerjee
Phytomedicine (2025) Vol. 138, pp. 156364-156364
Closed Access | Times Cited: 1
Anti-Inflammatory Effects of SGLT2 Inhibitors: Focus on Macrophages
Elena Y. Rykova, Vadim V. Klimontov, Elena Kazakova, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1670-1670
Open Access | Times Cited: 1
The role of the transcription factor NF-kB in the pathogenesis of inflammation and carcinogenesis. Modulation capabilities
Maria Moneva-Sakelarieva, Yozlem Kobakova, Spiro Konstantinov, et al.
Pharmacia (2025) Vol. 72, pp. 1-13
Open Access | Times Cited: 1
Interference With the AMPKα/mTOR/NLRP3 Signaling and the IL-23/IL-17 Axis Effectively Protects Against the Dextran Sulfate Sodium Intoxication in Rats: A New Paradigm in Empagliflozin and Metformin Reprofiling for the Management of Ulcerative Colitis
Mahmoud E. Youssef, Eslam E. Abd El-Fattah, A. M. Abdelhamid, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 46
Role of Sodium-Glucose Co-Transporter 2 Inhibitors in the Regulation of Inflammatory Processes in Animal Models
Sandra Feijóo‐Bandín, Alana Aragón‐Herrera, Manuel Otero-Santiago, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5634-5634
Open Access | Times Cited: 34
Anti-Inflammatory Properties of the SGLT2 Inhibitor Empagliflozin in Activated Primary Microglia
Marvin Heimke, Florian Lenz, Uta Rickert, et al.
Cells (2022) Vol. 11, Iss. 19, pp. 3107-3107
Open Access | Times Cited: 31
Peptide-Based Vaccines and Therapeutics for COVID-19
Pritam V. Bagwe, Priyal Bagwe, Sai Srinivas Ponugoti, et al.
International Journal of Peptide Research and Therapeutics (2022) Vol. 28, Iss. 3
Open Access | Times Cited: 29
Immunomodulation and immunopharmacology in heart failure
George Markousis‐Mavrogenis, Lukas Baumhove, Ali A. Al‐Mubarak, et al.
Nature Reviews Cardiology (2023) Vol. 21, Iss. 2, pp. 119-149
Closed Access | Times Cited: 22
The anti-inflammatory and immunological properties of SGLT-2 inhibitors
Giulia Bendotti, Laura Montefusco, Ida Pastore, et al.
Journal of Endocrinological Investigation (2023) Vol. 46, Iss. 12, pp. 2445-2452
Closed Access | Times Cited: 20
Single-Cell RNA Sequencing Reveals Metabolic Stress-Dependent Activation of Cardiac Macrophages in a Model of Dyslipidemia-Induced Diastolic Dysfunction
Cristina Panico, Arianna Felicetta, Paolo Kunderfranco, et al.
Circulation (2023) Vol. 150, Iss. 19, pp. 1517-1532
Closed Access | Times Cited: 19
Role of ICAM1 in tumor immunity and prognosis of triple-negative breast cancer
Qin Zhou, Jiawei Xu, Yan Xu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
GLP-1 Analogs, SGLT-2, and DPP-4 Inhibitors: A Triad of Hope for Alzheimer’s Disease Therapy
Magdalena Złotek, Antonina Kurowska, Mariola Herbet, et al.
Biomedicines (2023) Vol. 11, Iss. 11, pp. 3035-3035
Open Access | Times Cited: 17
Narrative Review of Immunomodulatory and Anti-inflammatory Effects of Sodium-Glucose Cotransporter 2 Inhibitors: Unveiling Novel Therapeutic Frontiers
Sul A Lee, Leonardo V. Riella
Kidney International Reports (2024) Vol. 9, Iss. 6, pp. 1601-1613
Open Access | Times Cited: 7
Sodium–glucose cotransporter 2 inhibitors and the cancer patient: from diabetes to cardioprotection and beyond
Massimiliano Camilli, Marcello Viscovo, Luca Maggio, et al.
Basic Research in Cardiology (2024)
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top